Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 1998

View Archived Issues

CoCensys announces clinical results from phase II migraine trial

New dental agent reduces bleeding and plaque formation in patients with gingivitis

P&U amends NDA for once-monthly contraceptive injection

Ionotropic glutamate receptor ligands described by Lilly for CNS disorders

Anti-HIV-1 TBZ analogues synthesized and evaluated by European academic group

Copper conjugates inhibit influenza virus replication in vitro

Robustaflavone: synergistic anti-HBV activity observed in combination with 3TC and penciclovir

Symbollon begins evaluating fibrocystic breast disease therapeutic in the clinic

Melagatran in different vehicles compared in rat model of thrombosis

Latest preclinical data further supports antiasthmatic efficacy of betotastine besilate

Alpha2-adrenoceptor antagonists useful as adjuncts to L-DOPA in PD

Launch of Innotest Beta-Amyloid(1-42) test enables more reliable diagnosis of AD

NDA submitted for new inhaled influenza medication

CE Mark approval granted for AastromReplicell system components

Baxter, Inhale will seek partner to continue development of drug candidate

Genetronics targets prostate cancer as a new indication for electroporation therapy

Schering-Plough obtains promising results in phase I study of p53 gene therapy for NSCLC

Pivotal clinical trial results with i.v. Hectorol support NDA submission

Medeva seeks E.U. approval for third-generation hepatitis B vaccine

IDEA licenses drug delivery technology to Procter & Gamble

Purepac's generic diltiazem capsules tentatively approved by FDA

Complement inhibitor TP10 improves outcome in pig model of bypass surgery

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Human trials of new liposomal ether lipid approved by FDA

RU-58841 shows potential as topical agent for alopecia and other skin disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...